What does high TPO antibodies mean?

High TPO antibodies indicate your immune system is attacking your thyroid gland, most commonly seen in Hashimoto's thyroiditis and other autoimmune thyroid conditions. While elevated levels don't always cause symptoms, they increase your risk of developing hypothyroidism and require monitoring.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding TPO Antibodies and Their Role in Thyroid Health

Thyroid peroxidase (TPO) antibodies are autoantibodies that your immune system produces when it mistakenly identifies thyroid peroxidase—an enzyme crucial for thyroid hormone production—as a foreign threat. When these antibodies are elevated, it signals that your immune system is attacking your thyroid gland, a condition known as autoimmune thyroiditis.

TPO is an enzyme found on the surface of thyroid cells that plays a vital role in producing thyroid hormones T3 (triiodothyronine) and T4 (thyroxine). These hormones regulate numerous bodily functions, including metabolism, heart rate, body temperature, and energy levels. When TPO antibodies interfere with this enzyme, they can disrupt hormone production and lead to thyroid dysfunction.

The presence of high TPO antibodies is one of the most sensitive markers for autoimmune thyroid disease. Studies show that up to 90% of people with Hashimoto's thyroiditis and 75% of those with Graves' disease test positive for TPO antibodies. However, it's important to note that some people with elevated TPO antibodies may never develop clinical thyroid disease.

TPO Antibody Reference Ranges and Clinical Significance

TPO Antibody LevelInterpretationClinical SignificanceRecommended Action
<20 IU/mL<20 IU/mLNormal/NegativeLow risk of autoimmune thyroid diseaseNo specific action needed
20-35 IU/mL20-35 IU/mLBorderlineSlightly elevated; may indicate early autoimmune activityConsider retesting in 6-12 months
35-100 IU/mL35-100 IU/mLMildly ElevatedSuggests autoimmune thyroid diseaseMonitor thyroid function every 6-12 months
>100 IU/mL>100 IU/mLSignificantly ElevatedStrong indication of autoimmune thyroid diseaseRegular monitoring; treat if thyroid dysfunction present

Reference ranges may vary between laboratories. Results should be interpreted alongside thyroid function tests and clinical symptoms.

Normal vs. High TPO Antibody Levels

Understanding what constitutes a normal versus high TPO antibody level is crucial for proper interpretation of your test results. Laboratory reference ranges can vary slightly, but generally, TPO antibody levels are measured in international units per milliliter (IU/mL).

Most laboratories consider TPO antibody levels below 35 IU/mL to be normal, though some use a cutoff of 20 IU/mL. Levels above these thresholds are considered positive or elevated. The higher the antibody level, the more likely it indicates active autoimmune thyroid disease. However, the absolute number doesn't always correlate with symptom severity.

It's worth noting that approximately 10-15% of healthy individuals, particularly women and older adults, may have slightly elevated TPO antibodies without any thyroid dysfunction. This is why TPO antibody testing is typically done alongside other thyroid function tests like TSH, Free T4, and Free T3 for a complete picture of thyroid health.

Common Conditions Associated with High TPO Antibodies

Hashimoto's Thyroiditis

Hashimoto's thyroiditis is the most common cause of elevated TPO antibodies and the leading cause of hypothyroidism in developed countries. In this condition, the immune system's attack on the thyroid gland leads to chronic inflammation and gradual destruction of thyroid tissue. Over time, this damage reduces the gland's ability to produce adequate thyroid hormones.

Research indicates that 90-95% of people with Hashimoto's have elevated TPO antibodies. The condition affects women 5-10 times more frequently than men and often runs in families. Early stages may present with no symptoms, but as the disease progresses, patients typically develop signs of hypothyroidism.

Graves' Disease

While Graves' disease is primarily associated with TSH receptor antibodies, approximately 70-80% of patients also have elevated TPO antibodies. Graves' disease causes hyperthyroidism—an overactive thyroid—and can lead to symptoms like rapid heartbeat, weight loss, anxiety, and bulging eyes (Graves' ophthalmopathy).

Postpartum Thyroiditis

This condition affects 5-10% of women within the first year after childbirth. Women with pre-existing TPO antibodies have a 30-50% chance of developing postpartum thyroiditis. The condition typically involves a hyperthyroid phase followed by hypothyroidism, though many women recover normal thyroid function within 12-18 months.

Symptoms and Health Implications of High TPO Antibodies

The presence of high TPO antibodies alone may not cause symptoms. Many people with elevated antibodies have normal thyroid function and feel perfectly healthy. However, as autoimmune thyroid disease progresses, various symptoms may develop depending on whether the thyroid becomes underactive (hypothyroid) or overactive (hyperthyroid).

Common symptoms associated with thyroid dysfunction from high TPO antibodies include:

  • Fatigue and weakness
  • Weight changes (gain with hypothyroidism, loss with hyperthyroidism)
  • Hair loss or thinning
  • Dry skin and brittle nails
  • Cold or heat intolerance
  • Mood changes, including depression or anxiety
  • Irregular menstrual periods
  • Muscle aches and joint pain
  • Brain fog and difficulty concentrating
  • Constipation or diarrhea

Beyond immediate symptoms, high TPO antibodies carry long-term health implications. Studies show that people with elevated TPO antibodies have an increased risk of developing clinical hypothyroidism over time, even if their initial thyroid function tests are normal. The annual rate of progression to hypothyroidism is approximately 2-4% in those with positive antibodies.

Additionally, high TPO antibodies have been associated with increased cardiovascular risk, fertility issues, and pregnancy complications including miscarriage and preterm birth. This underscores the importance of monitoring and managing thyroid health, especially in women of childbearing age. Regular testing can help catch thyroid dysfunction early and guide appropriate treatment.

Diagnosis and Testing for TPO Antibodies

TPO antibody testing is a simple blood test that can be performed alongside other thyroid function tests. Your healthcare provider may recommend this test if you have symptoms of thyroid dysfunction, a family history of thyroid disease, or other autoimmune conditions.

A comprehensive thyroid evaluation typically includes:

  • TSH (Thyroid Stimulating Hormone) - the most sensitive marker of thyroid function
  • Free T4 - the main thyroid hormone in circulation
  • Free T3 - the active form of thyroid hormone
  • TPO antibodies - to assess for autoimmune thyroid disease
  • Thyroglobulin antibodies - another marker of autoimmune thyroid disease
  • TSH receptor antibodies - specifically for diagnosing Graves' disease

The timing of testing can be important. TPO antibody levels can fluctuate, particularly during pregnancy, after viral infections, or with certain medications. If your initial test shows borderline results or if symptoms persist despite normal results, your doctor may recommend repeat testing in 3-6 months.

Treatment Options for High TPO Antibodies

Treatment for high TPO antibodies depends on whether thyroid function is affected. If your thyroid hormone levels are normal despite elevated antibodies, your doctor may recommend a watch-and-wait approach with regular monitoring. However, if thyroid dysfunction is present, treatment typically involves thyroid hormone replacement therapy.

Medical Treatment

For hypothyroidism caused by autoimmune thyroid disease, levothyroxine (synthetic T4) is the standard treatment. This medication replaces the thyroid hormone your body isn't producing adequately. The goal is to normalize TSH levels and alleviate symptoms. Some patients may benefit from combination therapy with T3, though this remains controversial.

In cases of hyperthyroidism from Graves' disease, treatment options include antithyroid medications (methimazole or propylthiouracil), radioactive iodine therapy, or thyroid surgery. The choice depends on factors like age, pregnancy status, and disease severity.

Lifestyle and Dietary Approaches

While medication addresses thyroid hormone levels, lifestyle modifications can help manage autoimmune activity and support overall thyroid health:

  • Anti-inflammatory diet: Focus on whole foods, omega-3 fatty acids, and antioxidant-rich fruits and vegetables
  • Gluten-free diet: Some studies suggest gluten elimination may reduce antibody levels in certain individuals
  • Selenium supplementation: 200 mcg daily may help reduce TPO antibodies and improve thyroid function
  • Vitamin D optimization: Adequate vitamin D levels support immune function and may reduce autoimmune activity
  • Stress management: Chronic stress can worsen autoimmune conditions; consider meditation, yoga, or counseling
  • Regular exercise: Moderate activity supports immune function and thyroid health
  • Adequate sleep: Aim for 7-9 hours nightly to support immune regulation

Monitoring and Long-term Management

If you have high TPO antibodies, regular monitoring is essential, even if your thyroid function is currently normal. The frequency of testing depends on your individual situation but typically ranges from every 6-12 months for those with normal thyroid function to every 6-12 weeks when initiating or adjusting treatment.

Key aspects of long-term management include:

  • Regular thyroid function testing (TSH, Free T4, Free T3)
  • Monitoring for symptoms of thyroid dysfunction
  • Annual screening for related conditions (cardiovascular disease, osteoporosis)
  • Medication adherence and dose adjustments as needed
  • Lifestyle modifications to support thyroid and immune health
  • Coordination with healthcare providers during pregnancy or when planning pregnancy

It's important to work closely with your healthcare provider to develop a personalized monitoring plan. Some people with high TPO antibodies never develop thyroid problems, while others may experience fluctuating thyroid function over time. Regular testing helps ensure any changes are caught early and treated appropriately.

Living Well with High TPO Antibodies

A diagnosis of high TPO antibodies can feel overwhelming, but with proper management, most people lead healthy, normal lives. The key is understanding your condition, maintaining regular monitoring, and taking proactive steps to support your thyroid and overall health.

Remember that having high TPO antibodies doesn't guarantee you'll develop thyroid disease. Many factors influence whether antibodies lead to clinical dysfunction, including genetics, environmental triggers, stress levels, and overall health status. By focusing on modifiable factors like diet, stress management, and regular monitoring, you can optimize your thyroid health regardless of antibody status.

If you're concerned about your thyroid health or have a family history of thyroid disease, consider getting comprehensive thyroid testing that includes TPO antibodies. Early detection and management of thyroid dysfunction can prevent complications and help you maintain optimal health and vitality throughout your life.

References

  1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.[PubMed][DOI]
  2. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646-2655.[PubMed][DOI]
  3. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68.[PubMed][DOI]
  4. Prummel MF, Wiersinga WM. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab. 2005;19(1):1-15.[PubMed][DOI]
  5. Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O'Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010;95(3):1095-1104.[PubMed][DOI]
  6. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011;342:d2616.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my TPO antibodies at home?

You can test your TPO antibodies at home with SiPhox Health's Core Health Program by adding the Thyroid+ expansion, which includes TPO antibodies, Free T3, and Free T4 testing. The Ultimate 360 Health Program includes TPO antibodies in its comprehensive 50-biomarker panel without requiring any add-ons.

What is the normal range for TPO antibodies?

Most laboratories consider TPO antibody levels below 35 IU/mL to be normal, though some use a cutoff of 20 IU/mL. Levels above these thresholds are considered positive or elevated, indicating potential autoimmune thyroid activity.

Can high TPO antibodies go away on their own?

While TPO antibody levels can fluctuate over time, they rarely disappear completely once elevated. However, some people see reductions through lifestyle changes like stress management, dietary modifications, and selenium supplementation. The antibodies may remain elevated without causing thyroid dysfunction.

Should I treat high TPO antibodies if my thyroid function is normal?

If your thyroid hormone levels (TSH, Free T4, Free T3) are normal despite high TPO antibodies, treatment typically isn't necessary. However, regular monitoring every 6-12 months is recommended since you have an increased risk of developing thyroid dysfunction over time.

What's the difference between TPO antibodies and other thyroid antibodies?

TPO antibodies target thyroid peroxidase enzyme and are most common in Hashimoto's thyroiditis. Thyroglobulin antibodies (TgAb) also indicate autoimmune thyroid disease. TSH receptor antibodies (TRAb) are specific to Graves' disease and cause hyperthyroidism. Different antibodies help diagnose different thyroid conditions.

Can pregnancy affect TPO antibody levels?

Yes, pregnancy can affect TPO antibody levels, which typically decrease during pregnancy due to immune suppression but may rise postpartum. Women with positive TPO antibodies have higher risks of miscarriage, preterm birth, and postpartum thyroiditis, making monitoring during pregnancy especially important.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details